Observational Study of Obstructive Lung Disease (NOVELTY)
Public ClinicalTrials.gov record NCT02760329. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A NOVEL Observational longiTudinal studY on Patients With Asthma and/or COPD to Describe Patient Characteristics, Treatment Patterns and the Burden of Illness Over Time and to Identify Phenotypes and Endotypes.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The NOVEL Observational longiTudinal studY (NOVELTY) is an observational study of obstructive lung disease and is a multi-country, multi-centre, prospective, longitudinal cohort study which will recruit patients with a diagnosis, or suspected diagnosis, of asthma and/or Chronic Obstructive Pulmonary Disease (COPD). Patients will undergo clinical assessments and receive standard medical care as determined by their treating physician. Patients enrolled in NOVELTY will be followed up yearly by their treating physician for a total duration of three years. In addition, patients will be followed up remotely every 3 months. The NOVELTY study will collect data currently lacking to allow for multinational data collection to fill regional/local gaps and improve comparability across regions.
Study identification
- NCT ID
- NCT02760329
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 12,255 participants
Conditions and interventions
Conditions
Interventions
- Blood draw Procedure
- Urine Procedure
- Lung function measurements Procedure
- Fractional Exhaled Nitric Oxide (FENO) Procedure
Procedure
Eligibility (public fields only)
- Age range
- 12 Years to 130 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 25, 2016 (Actual)
- Primary completion
- May 31, 2023 (Actual)
- Completion
- May 31, 2023 (Actual)
- Last update posted
- Oct 3, 2024
2016 – 2023
United States locations
- U.S. sites
- 40
- U.S. states
- 19
- U.S. cities
- 36
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Loma Linda | California | 92357 | — |
| Research Site | Long Beach | California | 90822 | — |
| Research Site | Roseville | California | 95661 | — |
| Research Site | Aurora | Colorado | 80045 | — |
| Research Site | Colorado Springs | Colorado | 80907 | — |
| Research Site | Clearwater | Florida | 33765-2103 | — |
| Research Site | Gainesville | Florida | 32608-1197 | — |
| Research Site | Miami | Florida | 33032 | — |
| Research Site | Miami | Florida | 33125 | — |
| Research Site | Plantation | Florida | 33322 | — |
| Research Site | Chicago | Illinois | 60612 | — |
| Research Site | Normal | Illinois | 61761 | — |
| Research Site | Hutchinson | Kansas | 67502 | — |
| Research Site | Shreveport | Louisiana | 71103 | — |
| Research Site | Fall River | Massachusetts | 02720 | — |
| Research Site | Ann Arbor | Michigan | 48106 | — |
| Research Site | Buckley | Michigan | 49620 | — |
| Research Site | Hamtramck | Michigan | 48212 | — |
| Research Site | Lincoln | Nebraska | 68505 | — |
| Research Site | Highland Park | New Jersey | 08904 | — |
| Research Site | West Berlin | New Jersey | 08091 | — |
| Research Site | Albuquerque | New Mexico | 87109 | — |
| Research Site | New York | New York | 10001 | — |
| Research Site | New York | New York | 10016 | — |
| Research Site | Rockville Centre | New York | 11570 | — |
| Research Site | The Bronx | New York | 10459 | — |
| Research Site | The Bronx | New York | 10461 | — |
| Research Site | The Bronx | New York | 10465 | — |
| Research Site | Fargo | North Dakota | 58104 | — |
| Research Site | Cincinnati | Ohio | 45242 | — |
| Research Site | Kettering | Ohio | 45439 | — |
| Research Site | Wooster | Ohio | 44691 | — |
| Research Site | Altoona | Pennsylvania | 16602 | — |
| Research Site | Providence | Rhode Island | 02914 | — |
| Research Site | Austin | Texas | 78731 | — |
| Research Site | Houston | Texas | 77079 | — |
| Research Site | Live Oak | Texas | 78233 | — |
| Research Site | San Antonio | Texas | 78023 | — |
| Research Site | Richmond | Virginia | 23219 | — |
| Research Site | Charleston | West Virginia | 25304 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 291 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02760329, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 3, 2024 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02760329 live on ClinicalTrials.gov.